Related references
Note: Only part of the references are listed.Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop
Shubbir Ahmed et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
T Cell Memory: Understanding COVID-19
Nicholas N. Jarjour et al.
IMMUNITY (2021)
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie J. Ewer et al.
NATURE MEDICINE (2021)
Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics
Dapeng Zhou et al.
GLYCOBIOLOGY (2021)
Nglyc: A Random Forest Method for Prediction of N-Glycosylation Sites in Eukaryotic Protein Sequence
Ganesan Pugalenthi et al.
PROTEIN AND PEPTIDE LETTERS (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Coronaviruses and SARS-CoV-2: A Brief Overview
Stephan Ludwig et al.
ANESTHESIA AND ANALGESIA (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Chunyan Yi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak
Liangjun Chen et al.
EMERGING MICROBES & INFECTIONS (2020)
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
Sampath K. Loganathan et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
Cuiqing Ma et al.
MICROBES AND INFECTION (2020)
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
Peter J. Hotez et al.
MICROBES AND INFECTION (2020)
The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Yosra A. Helmy et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo et al.
IMMUNITY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
Jun Wu et al.
FRONTIERS IN MICROBIOLOGY (2020)
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naive semisynthetic library
Hilal Ahmad Parray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Antoni G. Wrobel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and interactions
Yingjie Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Zunlong Ke et al.
NATURE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
Oliver C. Grant et al.
SCIENTIFIC REPORTS (2020)
Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells
Claudia R. Arbeitman et al.
SCIENTIFIC REPORTS (2020)
High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
Jinghua Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
Cathleen Lutz et al.
HUMAN GENOMICS (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat
Jun Zheng
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response
Tripti Shrivastava et al.
VACCINE (2018)
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
Wenfei Song et al.
PLOS PATHOGENS (2018)
The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256
Michiel T. van Diepen et al.
PLOS ONE (2018)
Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules
Isabelle Legastelois et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein
Shubbir Ahmed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile
Signe Tandrup Schmidt et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Different human vaccine adjuvants promote distinct antigenin-dependent immunological signatures tailored to different pathogens
Niels Peter H. Knudsen et al.
SCIENTIFIC REPORTS (2016)
Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes
Bradford S. Powell et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
T cell-mediated immune response to respiratory coronaviruses
Rudragouda Channappanavar et al.
IMMUNOLOGIC RESEARCH (2014)
Deciphering key features in protein structures with the new ENDscript server
Xavier Robert et al.
NUCLEIC ACIDS RESEARCH (2014)
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate
Wen-Hsiang Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Mechanism of immunopotentiation and safety of aluminum adjuvants
Harm HogenEsch
FRONTIERS IN IMMUNOLOGY (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Understanding the T cell immune response in SARS coronavirus infection
Hsueh-Ling Janice Oh et al.
EMERGING MICROBES & INFECTIONS (2012)
Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain
John E. Pak et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine
Alexander N. Zakhartchouk et al.
VACCINE (2007)
Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R
William C. Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody
Ponraj Prabakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization
Samitabh Chakraborti et al.
VIROLOGY JOURNAL (2005)
Type 1 type 2 immunity in infectious diseases
B Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2001)